Skip to content

Evaluation of Duodenal Mucosal Admittance Index in Patients with Functional Dyspepsia (FD)

Evaluation of Duodenal Mucosal Admittance Index in Patients with Functional Dyspepsia (FD) - Evaluation of Duodenal Mucosal Admittance Index in Patients with Functional Dyspepsia (FD)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000021397
Enrollment
50
Registered
2016-03-31
Start date
2015-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional dyspepsia

Interventions

Sponsors

Chiba University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients who are diagnosed functional dyspepsia by Rome III criteria. 2. Patients who are older than 20 years old. 3. Patients from whom written informed consent is obtained.

Exclusion criteria

Exclusion criteria: 1.Patients who have a history of pacemaker or ICD implantation. 2. Patients who have a history of electrical device implantation to brain such as deep brain stimulation. 3. Patients whose conditions are likely to cause upper abdominal symptoms such as malignant tumors, peptic ulcers, and systemic diseases (neurological diseases including Parkinson's disease, metabolic diseases including diabetes, etc.). 4. Patients with predominant GERD. 5. Patients who are suspicious for IBS. 6. Patients who have a history of upper gastrointestinal tract operation. 7. Patients who have a history of brain structural disease including schizophrenia, and depression. 8. Patients who have severe disorder of cardiovascular, liver or renal function, infection, and hematopoietic organ. 9. Patients who are taking aspirin, NSAIDs, corticosteroids or other immunosuppressive drugs. 10. Patients whose causes of dyspepsia are considered excessive drinking, overeating, and severe stress. 11. Patients who are alcohol or drug dependent. 12. Pregnancy or lactation woman. Patients who hope pregnancy during study. 13. Patients who took H. pylori eradication therapy within 6 months. 14. Patients who are judged as being inappropriate for this study by their medical doctor.

Design outcomes

Primary

MeasureTime frame
Duodenal mucosal admittance index of FD patients and healthy subjects

Countries

Japan

Contacts

Public ContactHideaki Ishigami

Chiba University Hospital Gastroenterology

ishigami-ncu@umin.ac.jp043-226-2083

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026